Oriens Bio Care Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 12-07-2024
- Paid Up Capital ₹ 0.10 M
as on 12-07-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2019)
- Ebitda
- Net Worth
- Total Assets %
(FY 2019)
About Oriens Bio Care
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rangappan Ravi, Periasamy Karthikeyan, and Sundararajan Shankar serve as directors at the Company.
- CIN/LLPIN
U51397TN2009PTC073598
- Company No.
073598
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Oriens Bio Care?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Periasamy Karthikeyan  | Managing Director | 19-Nov-2009 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rangappan Ravi | Director | 17-Mar-2023 | Current |
| Sundararajan Shankar | Director | 19-Nov-2009 | Current |
Financial Performance of Oriens Bio Care.
Oriens Bio Care Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Oriens Bio Care?
In 2016, Oriens Bio Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vijayani Nutraceuticals Private LimitedActive 9 years 7 monthsPeriasamy Karthikeyan and Sundararajan Shankar are mutual person
Oriens Global Marketing Private LimitedActive 14 years 11 monthsPeriasamy Karthikeyan and Sundararajan Shankar are mutual person
Vijayani Laboratories Private LimitedActive 2 years 5 monthsPeriasamy Karthikeyan and Sundararajan Shankar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oriens Bio Care?
Unlock and access historical data on people associated with Oriens Bio Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oriens Bio Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oriens Bio Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
